271 related articles for article (PubMed ID: 24590389)
1. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis.
Liew WK; Powell CA; Sloan SR; Shamberger RC; Weldon CB; Darras BT; Kang PB
JAMA Neurol; 2014 May; 71(5):575-80. PubMed ID: 24590389
[TBL] [Abstract][Full Text] [Related]
2. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
[TBL] [Abstract][Full Text] [Related]
3. Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis.
Barnett C; Wilson G; Barth D; Katzberg HD; Bril V
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):94-7. PubMed ID: 23154126
[TBL] [Abstract][Full Text] [Related]
4. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
[TBL] [Abstract][Full Text] [Related]
5. Update on juvenile myasthenia gravis.
Liew WK; Kang PB
Curr Opin Pediatr; 2013 Dec; 25(6):694-700. PubMed ID: 24141560
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of therapeutic options used for myasthenia gravis.
Mandawat A; Kaminski HJ; Cutter G; Katirji B; Alshekhlee A
Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
[TBL] [Abstract][Full Text] [Related]
7. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
Pittayanon R; Treeprasertsuk S; Phanthumchinda K
J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
[TBL] [Abstract][Full Text] [Related]
9. IVIG and PLEX in the treatment of myasthenia gravis.
Bril V; Barnett-Tapia C; Barth D; Katzberg HD
Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
11. Safety of plasma exchange therapy in patients with myasthenia gravis.
Ebadi H; Barth D; Bril V
Muscle Nerve; 2013 Apr; 47(4):510-4. PubMed ID: 23322564
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to immunomodulation in patients with myasthenia gravis.
Katzberg HD; Barnett C; Bril V
Muscle Nerve; 2012 May; 45(5):648-52. PubMed ID: 22499090
[TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis Versus Intravenous Immunoglobulin in Patients With Autoimmune Neuromuscular and Neuro-immunological Conditions.
Zubair AS; Rethana M; Ma A; McAlpine LS; Abulaban A; Munro BS; Patwa HS; Nowak RJ; Roy B
J Clin Neuromuscul Dis; 2023 Sep; 25(1):11-17. PubMed ID: 37611265
[TBL] [Abstract][Full Text] [Related]
14. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of pediatric ocular myasthenia gravis.
Ortiz S; Borchert M
Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
[TBL] [Abstract][Full Text] [Related]
16. Comparison of IVIg and PLEX in patients with myasthenia gravis.
Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of juvenile myasthenia gravis after extended transsternal thymectomy in a chinese cohort.
Cheng C; Liu Z; Xu F; Deng Z; Feng H; Lei Y; Zou J; Yeung SC
Ann Thorac Surg; 2013 Mar; 95(3):1035-41. PubMed ID: 23374447
[TBL] [Abstract][Full Text] [Related]
18. Juvenile myasthenia gravis: a twenty-year experience.
Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
[TBL] [Abstract][Full Text] [Related]
19. Assessing the comparative efficacy of plasmapheresis and Intravenous immunoglobulin in myasthenia gravis treatment: A systematic review and meta-analysis.
Ghimire A; Kunwar B; Aryal B; Gaire A; Bist A; Shah B; Mainali A; Ghimire B; Gajurel BP
J Clin Neurosci; 2024 Mar; 121():1-10. PubMed ID: 38306763
[TBL] [Abstract][Full Text] [Related]
20. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
